SKORLONT
Live / Registered — Registered (as of 25 Aug 2020)
What this means for you
Registered since 25 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88365484
- Registration number
- 6133181
- Mark type
- Stylized text
- Filed
- 01 Apr 2019
- Published for opposition
- 09 Jun 2020
- Registered
- 25 Aug 2020
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Owner
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prior registrations
Prosecution history
- 25 Aug 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 08 Nov 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Nov 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Nov 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 09 Jun 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2020 — PUBLISHED FOR OPPOSITION
- 20 May 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 May 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Apr 2020 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Apr 2020 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Apr 2020 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Mar 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2020 — NON-FINAL ACTION E-MAILED
- 27 Mar 2020 — NON-FINAL ACTION WRITTEN